¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"adenylate charge hypothesis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate kinase
    ¾Æµ¥´Ò»êŰ³ª¾ÆÁ¦
  • hypothesis
    °¡¼³
  • lattice hypothesis
    °ÝÀÚ°¡¼³
  • null hypothesis
    ¿µ°¡¼³, ±Í¹«°¡¼³
  • unitarian hypothesis
    Ç×üµ¿Àϰ¡¼³
  • charge
    1. ÀüÇÏ, ÇÏÀü 2. ÃæÀü
  • charge to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • effective charge
    À¯È¿ÀüÇÏ
  • electric charge
    ÀüÇÏ
  • electronic charge
    ÀüÀÚÀüÇÏ
  • membrane charge
    ¸·ÀüÇÏ
  • negative charge
    À½ÀüÇÏ
  • point charge
    Á¡ÇÏÀü
  • polarization charge
    ºÐ±ØÇÏÀü
  • specific charge
    ºñÀüÇÏ, °ßÁÜÀüÇÏ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • charge
    ÀüÇÏ, ÇÏÀü, ÃæÀü
  • hypothesis
    °¡¼³
  • null hypothesis
    ±Í¹«°¡¼³, ¿µ°¡¼³
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • charge
    ÀüÇÏ, ÇÏÀü, ÃæÀü
  • charge to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • effective charge
    À¯È¿ÀüÇÏ
  • electric charge
    ÀüÇÏ
  • electronic charge
    ÀüÀÚÀüÇÏ
  • membrane charge
    ¸·ÀüÇÏ
  • negative charge
    À½ÀüÇÏ
  • point charge
    Á¡ÇÏÀü
  • polarization charge
    ºÐ±ØÇÏÀü
  • specific charge
    °ßÁÜÀüÇÏ, ºñÀüÇÏ
  • blending hypothesis
    À¶ÇÕÀ¯Àü¼³
  • central plasticity hypothesis
    ÁßÃßÀ¯¿¬¼º°¡¼³
  • countercurrent hypothesis
    ¿ª·ù°¡¼³
  • drift hypothesis
    À̵¿°¡¼³
  • dual recognition hypothesis
    Ç׿øÀÌÁßÀÎÁö°¡¼³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×ÀÌÁî, ¾Æµ¥´Ò·¹ÀÌÆ®Å°³ªÁ¦
  • adenylate cyclase
    ¾Æµ¥´Ò·¹ÀÌÆ® »çÀÌŬ·¹À̽º.
  • adenylyl cyclase= adenyl cyclase= adenylate cyclase
    ¾Æµ¥´Ò»çÀÌŬ¶óÁ¦, ¾Æµ¥´Ò»çÀÌŬ·¹ÀÌÁî
  • point charge
    Á¡ÇÏÀü(ïÇùÃï³).
  • polarization charge
    ºÐ±ØÇÏÀü.
  • positive charge
    ¾çÀüÇÏ(åÕï³ùÃ).
  • Glucostatic hypothesis, of appetite regulation
    Ç×´ç±â¼³(ù÷ÓØÐñæò), ½Ä¿åÁ¶Àý(ãÝé¯ðàï½)
  • Lyon s hypothesis
    ¶óÀ̿°¡¼³.
  • Starling s hypothesis
    ½ºÅ¸¾Ë¸µ°¡¼³.
  • hypothesis, lattice
    °ÝÀÚ¼³
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×ÀÌÁî, ¾Æµ¥´Ò·¹ÀÌÆ®Å°³ªÁ¦
  • adenylate cyclase
    ¾Æµ¥´Ò·¹ÀÌÆ® »çÀÌŬ·¹À̽º.
  • adenylyl cyclase= adenyl cyclase= adenylate cyclase
    ¾Æµ¥´Ò»çÀÌŬ¶óÁ¦, ¾Æµ¥´Ò»çÀÌŬ·¹ÀÌÁî
  • charge
    ÀüÇÏ(ï³ùÃ), ÇÏÀü, ÃæÀü(õöï³)
  • charge-to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • doctor in charge
    ÁÖÄ¡ÀÇ(ñ«ö½ì¢).
  • doctor in charge
    ÁÖÄ¡ÀÇ(̡̬Ëö).
  • effective charge
    À¯È¿ÀüÇÏ(¡­ï³ùÃ).
  • electric charge
    ÀüÇÏ(ï³ùÃ).
  • electric charge
    ÀüÇÏ(ï³ùÃ)
  • electronic charge
    ÀüÀÚÀüÇÏ(ï³í­ï³ùÃ).
  • membrane charge
    ¸·ÀüÇÏ(دï³ùÃ).
  • negative charge
    À½ÇÏÀü, À½ÀüÇÏ(ëäï³ùÃ).
  • nuclear charge
    ÇÙÇÏÀü.
  • point charge
    Á¡ÇÏÀü(ïÇùÃï³).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate charge hypothesis
    ¾Æµ¥´Ò»ê(ß«)´ëÀü¼³(Óáï³àã)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate control hypothesis
    ¾Æµ¥´Ò»ê(ß«)Á¶Àý¼³(ðàï½àã)
  • active adenylate
    Ȱ¼º ¾Æµ¥´Ò»ê¿° (ß«ç¤)
  • adenylate
    ¾Æµ¥´Ò»ê¿°(ß«ç¤)
  • adenylate cyclase
    ¾Æµ¥´Ò·¹ÀÌÆ®»çÀÌŬ·¹À̽º
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×À̽º
  • adenylate pool
    ¾Æµ¥´Ò»ê(ß«) Ç®
  • aminoacyl adenylate
    ¾Æ¹Ì³ë¾Æ½Ç¾Æµ¥´Ò»ê(ß«)
  • charge density
    ÀüÇϹеµ(ï³ùÃÚËÓø)
  • charge effect
    ÀüÇÏÈ¿°ú(ï³ùÃüùÍý)
  • charge fluctuation interactions
    ÀüÇϺ¯µ¿»óÈ£ÀÛ¿ë(ï³ùÃܨÔÑßÓû»íÂéÄ)
  • charge relay system
    ÀüÇÏ(ï³ùÃ) ¸±·¹ÀÌ ½Ã½ºÅÛ
  • charge reversal spectrum
    ÀüÇÏ¿ªÀü (ï³ùÃæ½ï®) ½ºÆåÆ®·³
  • charge transfer complex
    ÀüÇÏÀ̵¿ º¹ÇÕü(ï³ùÃì¹ÔÑÜÜùêô÷)
  • charge transfer relay system
    ÀüÇÏÀ̵¿(ï³ùÃì¹ÔÑ) ¸±·¹ÀÌ ¾¾½ºÅÛ
  • energy charge
    ¿¡³ÊÁö ÃæÁ·À²(õöðëëÒ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothesis
    °¡¼³
  • CCD(charge coupled device)
    °íüÃÔ¿µ¼ÒÀÚ,CCD
  • negative charge
    À½ÇÏÀü, À½ÀüÇÏ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
e base of natural logarithms, approximately 2.7182818285; egg transfer; ejection; electric charge; ele...
H0 null hypothesis
H1 alternative hypothesis
LNH large number hypothesis
TRH tension-reducing hypothesis; thyrotropin-releasing hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AEC Adenylate energy charge
(3)H hypothesis that
CCD Charge Coupled Device
CT Charge transfer
EC Energy charge
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adenylate cyclase
    ¾Æµ¥´Ò·¹ÀÌÆ® »çÀÌŬ¶óÁ¦
    ATP¿¡¼­ c-AMP¸¦ ÇÕ¼ºÇÏ´Â ¿ä¼Ò·Î ¼¼Æ÷¸·¿¡ Á¸ÀçÇÑ´Ù. È£¸£¸ó ¼ö¿ëü¿Í ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Ù. À̸¦Å×¸é ±Û·çÄ«°ïÀº °£ ¼¼Æ÷¸·ÀÇ ÀÌ È¿¼Ò¸¦ Ȱ¼ºÈ­ÇÏ°í ¿¡Çdz×ÇÁ¸°Àº ±ÙÀ°¼¼Æ÷¸·ÀÇ ÀÌ È¿¼Ò¸¦ Ȱ¼ºÈ­ÇØ c-AMP¸¦ »ý¼ºÇÏ¿© ±Û¸®ÄÚ°ÕÀÇ ºÐÇØ¸¦ ÃËÁøÇÑ´Ù.
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ® Ä«À̳×À̽º
  • altered-self hypothesis
    º¯È­ÇÑ ÀÚ±â Ç׿ø °¡¼³
    T-B Çùµ¿ÀÛ¿ëÀ̳ª Killer T ¼¼Æ÷ÀÇ Ç¥Àû¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ À־ ¸²ÇÁ±¸´Â ¹ÝÀÀÇÏ´Â »ó´ëÀÇ ±¸Á¶·Î¼­ ºñÀÚ±âÀÎ Ç׿ø°ú ÀÚ±âÀÎ MHCÀÇ ¾çÂÊÀ» ÀνÄÇϰí ÀÖ´Ù. ÀÌ °æ¿ì »ý°¢ÇÏ´Â ¹æ½Ä¿¡ µÎ °³ÀÇ ¹æ½ÄÀÌ ÀÖÀ¸¸ç ºñÀÚ±â¿Í ÀڱⰡ ÇϳªÀÇ °ÍÀ¸·Î¼­ ÇÑ Á¾·ùÀÇ ¼ö¿ëü¿¡ ÀÇÇÏ¿© ÀÎ½ÄµÈ´Ù°í »ý°¢ÇÏ´Â °ÍÀÌ º¯È­ÇÑ ÀÚ°¡ Ç׿ø °¡¼³ÀÇ »ý°¢ ¹æ½ÄÀÌ´Ù.
  • convergence-projection hypothesis
    ÆøÁÖ Åõ»ç °¡¼³
  • dual recognition hypothesis
    2Áß Àνļ³
    ¸é¿ª ¼¼Æ÷ »çÀÌÀÇ »óÈ£ ÀÛ¿ë¿¡ À־ÀÇ T ¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ °üÇÑ °¡¼³ÀÇ Çϳª. T ¼¼Æ÷¿¡´Â ÀÚ±âÀÇ MHC ºÐÀÚ¸¦ ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü¿Í ´Ù¸¥ °ÍÀ» ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü°¡ °¢°¢ µ¶¸³ÇÏ¿© Á¸ÀçÇÑ´Ù°í ÇÏ´Â »ý°¢.
  • hypothesis
    °¡¼³
    ¸î °¡ÁöÀÇ Çö»óÀ» ¼³¸íÇÒ ¼ö ÀÖÀ¸¸ç Ãß·ÐÀ̳ª ½ÇÇèÀ» ±âÃÊ·Î ÇÏ¿© °¡Á¤µÈ ÃßÃø.
  • Starling's hypothesis
    ½ºÅ»¸µÀÇ °¡¼³
  • unitarian hypothesis
    Ç×ü µ¿Àϼ³
  • bioelectric charge
    »ý¹°ÇÐÀû Àü±â ÀüÇÏ, »ý¹°ÇÐÀû Àü±âÀû ÀüÇÏ
  • charge
    ÀüÇÏ, ÇÏÀü, ÃæÀü
  • doctor in charge
    ÁÖÄ¡ÀÇ
  • energy charge
    ¿¡³ÊÁö ºÎÇÏ
  • negative charge
    À½ ÇÏÀü, À½ ÀüÇÏ
  • nuclear charge
    ÇÙ ÇÏÀü
  • positive charge
    ¾ç ÀüÇÏ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adenylate Salt or ester of adenylic acid.
(05 Mar 2000)
adenylate cyclase <enzyme> Enzyme responsible for the ATP.
(06 May 1997)
adenylate kinase <enzyme> An enzyme that catalyses the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate.
Chemical name: ATP:AMP phosphotransferase
Registry number: EC 2.7.4.3
(12 Dec 1998)
aminoacyl adenylate The product formed by the condensation of the acyl radical of an amino acid and adenosine 5'-monophosphate (originally in the form of adenosine 5'-triphosphate, with elimination of a pyrophosphoric group). Formed in the first step of protein biosynthesis.
Synonym: activated amino acid.
(05 Mar 2000)
nucleoside triphosphate-adenylate kinase <enzyme> Other nucleoside triphosphates may replace GTP as substrate
Registry number: EC 2.7.4.10
Synonym: GTP-AMP phosphotransferase, AMP-GTP phosphotransferase
(26 Jun 1999)
luciferyl adenylate An intermediate compound in the pathway of bioluminescence. Its precursor is the pigment luciferin. It is the substrate of the enzyme luciferase, which combines it with oxygen to make visible light.
(09 Oct 1997)
charge 1. <physics> A fundamental physical attribute of a particle, which characterises the particle's electromagnetic interaction with other particles and with electric and magnetic fields.
2. Storing energy in a battery or electric capacitor by running a current through it, opposite of discharge. (It is possible to charge most capacitors in either direction, but batteries charge one way, and discharge in the other.)
(13 Nov 1997)
charge exchange <radiobiology> Phenomenon in which an ion colliding with a molecule (or an atom) neutralises itself by capturing an electron from the molecule or atom, and transforming the molecule or atom into a positive radical or ion.
(13 Nov 1997)
charge nurse A nurse administratively responsible for a designated hospital unit on an 8 hour basis.
Synonym: head nurse.
(05 Mar 2000)
charge transfer A complex between two organic molecules in which an electron from one (the donor) is transferred to the other (the acceptor), becoming generally distributed throughout the latter; subsequent transfer of a hydrogen atom completes the reduction of the acceptor; such complex's are generally highly coloured and may be so observed, a network of hydrogen bridges at the catalytic centre of certain proteases.
Synonym: charge transfer system.
(05 Mar 2000)
charge transfer complex A complex between two organic molecules in which an electron from one (the donor) is transferred to the other (the acceptor), becoming generally distributed throughout the latter; subsequent transfer of a hydrogen atom completes the reduction of the acceptor; such complex's are generally highly coloured and may be so observed, a network of hydrogen bridges at the catalytic centre of certain proteases.
Synonym: charge transfer system.
(05 Mar 2000)
charge transfer system A complex between two organic molecules in which an electron from one (the donor) is transferred to the other (the acceptor), becoming generally distributed throughout the latter; subsequent transfer of a hydrogen atom completes the reduction of the acceptor; such complex's are generally highly coloured and may be so observed, a network of hydrogen bridges at the catalytic centre of certain proteases.
Synonym: charge transfer system.
(05 Mar 2000)
specimen charge <microscopy> The electrical charge resulting from the impingement of electrons on a nonconducting specimen.
(05 Aug 1998)
adaptor hypothesis A hypothesis, proposed by F.H.C. Crick, that an adaptor molecule must be present between the information-containing DNA and the protein being synthesised.
(05 Mar 2000)
altered self hypothesis The hypothesis that the T-cell receptor in MHC mediated phenomena recognises a syngeneic MHC Class I or Class II molecule after modification by a virus or certain chemicals.
See: MHC restriction.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothesis
    °¡¼³
  • efficient market hypothesis
    (Áõ±Ç)È¿À²Àû ½ÃÀå °¡¼³(»õ·Î¿î Á¤º¸ÀÇ ÁÖ°¡¿¡ÀÇ ¹ÝÀÀÀº µ¿½ÃÀûÀ̶õ °¡¼³)
  • hypothesis
    °¡¼³;°¡Á¤
  • nebular hypothesis(theory)
    (õ)(žç°èÀÇ)¼º¿î¼³
  • charge
    û±¸ÇÏ´Ù,ÁüÀ»½Æ´Ù
  • carrying charge
    ¿ùºÎÀÇ ÇÒÁõ±Ý;ºÎµ¿»êÀÇ °è¼Ó ¼ÒÀ¯(»ç¿ë)¿¡ µå´Â ºñ¿ë(¼¼±Ý.º¸Çèµî);(»óǰ ¼ö¼ÛÀÇ)Á¦ºñ¿ë
  • charge
    =CHARGE D'AFFAIRES
  • charge
    ...¿¡ ä¿ì´Ù;Ãæ¸¸ÇÏ°Ô ÇÏ´Ù;(¸»µî¿¡)ÁüÀ» Áö¿ì´Ù;(...¿¡ ÁüÀ»)½Æ´Ù;(±×¸©¿¡)...À» Àç´Ù;(ÃÑÆ÷¿¡)È­¾àÀ» Àç´Ù;ÀåÀüÇÏ´Ù;(ÃàÀüÁö¿¡)ÃæÀüÇÏ´Ù;(Àǹ«.Ã¥ÀÓµîÀ»)Áö¿ì´Ù;°úÇÏ´Ù;À§Å¹ÇÏ´Ù;(±ÇÀ§¸¦ °¡Áö°í)¸í·ÉÇÏ´Ù;(ÀçÆÇ°ü.ÁÖ±³ µîÀÌ)¼³À¯(¼³¸í)ÇÏ´Ù;(ÁË.°ú½ÇµîÀ»)...Å¿À¸·Î µ¹¸®´Ù
  • charge
    ÅõÀÔ·®;Ã¥ÀÓ;Àǹ«;À§Å¹;º¸È£;°ü¸®;´ã´ç;¸ÃÀº °Í;¸í·É;Áö·É;ÈÆ·É;À¯½Ã;ºñ³­;°í¼Ò;°í¹ß;¹®Ã¥;ÁË;û±¸ ±Ý¾×;´ë°¡;¿ä±Ý;ºÎäÀÇ ±âÀÔ;ÁöºÒ °èÁ¤ÀÇ ±âÀç;¿Ü»ó(À¸·Î ´Þ±â);Áü;È­¹°;ºÎ´ã;°ú¼¼±Ý;¼¼±Ý;Â÷Áö;µ¹°Ý;µ¹Áø;Áø±º³ªÆÈ(ºÏ);¹®Àå¿¡ ±×·ÁÁ® ÀÖ´Â µµÇü;½º¸±;ÀÚ±Ø;ÈïºÐ;Áñ°Å¿î °æ
  • charge account
    ¿Ü»ó°Å·¡ °èÁ¤
  • charge card
    Å©·¹µðÆ® Ä«µå
  • charge conjugation
    ÇÏÀü °ø¾× º¯È¯
  • charge customer
    ¿Ü»ó¼Õ´Ô;½Å¿ë °Å·¡Ã³
  • charge d'affaires
    ´ë¸®´ë»ç(°ø»ç);°ø»ç´ë¸®(´ë»ç(°ø»ç)¾ø´Â ±¹°¡¿¡ µÒ))
  • charge hand
    Á÷Àå;Á¶Àå(Á÷Àå ´ÙÀ½ Á÷À§ÀÇ Á÷°ø) (
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á